ArticleInfection and drug resistance2026
Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020-2022 in China.
Yanfei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.